Quarterly Result13 Aug 2026, 02:43 pm
Advik Laboratories Ltd Declares Unaudited Q1 FY27 Results
AI Summary
Advik Laboratories Ltd (now MPS Pharmaa Limited) announced its standalone unaudited financial results for the quarter ended June 30, 2026. The Board of Directors approved the results and the limited review report during a meeting held on August 13, 2026. The company operates in a single segment, pharmaceuticals formulations. Management is actively exploring market and business opportunities and is in discussions with prospective buyers to finalize new deals, expressing confidence in restarting business operations.
Key Highlights
- Standalone unaudited financial results for Q1 FY27 declared.
- Board meeting held on August 13, 2026, approved the results.
- Company is exploring new business opportunities and deals.
- Management is confident in restarting business operations.
- Company operates in a single pharmaceutical formulations segment.
Price Impact
More from ADVIKLA